Whereas some miRNAs may directly contribute to the formation of AD neuropathology by regulating expression of key AD-related genes, such as APP, BACE1 or MAPT [13], others regulate the synaptic environment, by altering dendritic branching, neurite outgrowth and spine morphology [14–17]. This evidence concerns the gene MAPT and Alzheimer disease.